Company Overview and News

 
Nine-Fairfax deal's fate hinges on whether it's a merger or takeover

2018-10-16 theage.com.au
The question of whether Nine Entertainment’s bid for Fairfax Media is a takeover or a merger has become more relevant after the implosions in both companies’ share prices in recent weeks.
GJV NWS NWSA RPGRF REA RPGRY

 
Nine-Fairfax deal's fate hinges on whether it's a merger or takeover

2018-10-16 watoday.com.au
The question of whether Nine Entertainment’s bid for Fairfax Media is a takeover or a merger has become more relevant after the implosions in both companies’ share prices in recent weeks.
GJV NWS NWSA RPGRF REA RPGRY

 
Nine-Fairfax deal's fate hinges on whether it's a merger or takeover

2018-10-16 smh.com.au
The question of whether Nine Entertainment’s bid for Fairfax Media is a takeover or a merger has become more relevant after the implosions in both companies’ share prices in recent weeks.
GJV NWS NWSA RPGRF REA RPGRY

 
‘No longer confident’ Fairfax, Nine will merge as planned: Citi

2018-10-15 theage.com.au
Investor worries about media companies has put pressure on the proposed $3.2 billion merger of Fairfax Media and Nine Entertainment Co merger with analysts now valuing Fairfax above the bid price.
WANHY SWM RPGRF REA RPGRY WANHF

 
‘No longer confident’ Fairfax, Nine will merge as planned: Citi

2018-10-15 watoday.com.au
Investor worries about media companies has put pressure on the proposed $3.2 billion merger of Fairfax Media and Nine Entertainment Co merger with analysts now valuing Fairfax above the bid price.
WANHY SWM RPGRF REA RPGRY WANHF

 
‘No longer confident’ Fairfax, Nine will merge as planned: Citi

2018-10-15 smh.com.au
Investor worries about media companies has put pressure on the proposed $3.2 billion merger of Fairfax Media and Nine Entertainment Co merger with analysts now valuing Fairfax above the bid price.
WANHY SWM RPGRF REA RPGRY WANHF

 
Domain, Fairfax revenue slips ahead of merger with Nine

2018-10-12 theage.com.au
Investors have heavily sold off Nine Entertainment Co and Fairfax Media in the wake of trading updates released on Friday morning as part of the merger process between the media companies.
WANHY MRN SWM RPGRF REA RPGRY WANHF

 
Domain, Fairfax revenue slips ahead of merger with Nine

2018-10-12 watoday.com.au
Investors have heavily sold off Nine Entertainment Co and Fairfax Media in the wake of trading updates released on Friday morning as part of the merger process between the media companies.
WANHY MRN SWM RPGRF REA RPGRY WANHF

 
Domain, Fairfax revenue slips ahead of merger with Nine

2018-10-12 smh.com.au
Investors have heavily sold off Nine Entertainment Co and Fairfax Media in the wake of trading updates released on Friday morning as part of the merger process between the media companies.
WANHY MRN SWM RPGRF REA RPGRY WANHF

 
What the UK foreign buyer tax means for Hong Kong investors

2018-10-10 scmp
Britain’s status as a favoured investment destination for Hong Kong property buyers is expected to face headwinds from a proposed foreign buyers’ tax and uncertainties over Brexit.
RPGRF REA RPGRY

 
Tech investors are getting carried away

2018-09-25 smh.com.au
It’s a distant memory now, obscured by the more recent global financial crisis, but if you can find someone with a grey hair or three, they’ll tell you the tale of the dotcom boom and bust.
TNE RPGRF REA RPGRY

 
Opcity, Lead Conversion, And The Journey Down The Funnel

2018-09-12 seekingalpha
Last week, News Corp, owner of realtor.com in the U.S. and the majority owner of REA Group in Australia, announced the $210 million acquisition of lead qualification service Opcity.
GJV NWS NWSA RPGRF REA RPGRY

 
Planning changes to spread 'Silicon Yarra' to other suburbs

2018-09-11 theage.com.au
A new Victorian town planning category aims to encourage ‘new economy’ enterprises to inner-city suburbs such as Brunswick, South Melbourne and Collingwood, in the same way they have transformed the once-obscure industrial precinct of Cremorne into an entrepreneurial office hub.
RPGRF REA RPGRY

 
Planning changes to spread 'Silicon Yarra' to other suburbs

2018-09-11 smh.com.au
A new Victorian town planning category aims to encourage ‘new economy’ enterprises to inner-city suburbs such as Brunswick, South Melbourne and Collingwood, in the same way they have transformed the once-obscure industrial precinct of Cremorne into an entrepreneurial office hub.
RPGRF REA RPGRY

 
News Corp.'s Move To Acquire Opcity For Real Estate Lead Gen

2018-09-07 seekingalpha
NWS is smart to double down on its Move subsidiary, with digital real estate being the fastest-growing segment in the company.
GJV NWS NWS NWSA RPGRF REA RPGRY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 74945L106